These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 25373519)

  • 1. The cost and cost-effectiveness of gender-responsive interventions for HIV: a systematic review.
    Remme M; Siapka M; Vassall A; Heise L; Jacobi J; Ahumada C; Gay J; Watts C
    J Int AIDS Soc; 2014; 17(1):19228. PubMed ID: 25373519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of social protection on gender equality in low- and middle-income countries: A systematic review of reviews.
    Perera C; Bakrania S; Ipince A; Nesbitt-Ahmed Z; Obasola O; Richardson D; Van de Scheur J; Yu R
    Campbell Syst Rev; 2022 Jun; 18(2):e1240. PubMed ID: 36913187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations.
    Craig AP; Thein HH; Zhang L; Gray RT; Henderson K; Wilson D; Gorgens M; Wilson DP
    J Int AIDS Soc; 2014; 17(1):18822. PubMed ID: 24572053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing gender inequality and intimate partner violence as critical barriers to an effective HIV response in sub-Saharan Africa.
    Watts C; Seeley J
    J Int AIDS Soc; 2014; 17(1):19849. PubMed ID: 25499456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services.
    Chersich MF; Luchters S; Ntaganira I; Gerbase A; Lo YR; Scorgie F; Steen R
    J Int AIDS Soc; 2013 Mar; 16(1):17980. PubMed ID: 23462140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs.
    Reddon H; Marshall BDL; Milloy MJ
    Lancet HIV; 2019 Feb; 6(2):e128-e136. PubMed ID: 30558843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and economic evaluations of a combination prevention programme for men who have sex with men in Mexico.
    Colchero MA; Bautista-Arredondo S; Cortés-Ortiz MA; Romero-Martinez M; Salas J; Sosa-Rubí SG; Uribe P
    AIDS; 2016 Jan; 30(2):293-300. PubMed ID: 26691549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context.
    Wegbreit J; Bertozzi S; DeMaria LM; Padian NS
    AIDS; 2006 Jun; 20(9):1217-35. PubMed ID: 16816550
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.
    Creese A; Floyd K; Alban A; Guinness L
    Lancet; 2002 May; 359(9318):1635-43. PubMed ID: 12020523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
    Bórquez A; Guanira JV; Revill P; Caballero P; Silva-Santisteban A; Kelly S; Salazar X; Bracamonte P; Minaya P; Hallett TB; Cáceres CF
    Lancet Public Health; 2019 Mar; 4(3):e127-e136. PubMed ID: 30683587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
    Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
    PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cash transfers for HIV prevention: considering their potential.
    Heise L; Lutz B; Ranganathan M; Watts C
    J Int AIDS Soc; 2013 Aug; 16(1):18615. PubMed ID: 23972159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of Gender-Based Violence Prevention and Response Interventions for HIV Key Populations: Female Sex Workers, Men Who Have Sex With Men, and People Who Inject Drugs.
    Decker MR; Lyons C; Guan K; Mosenge V; Fouda G; Levitt D; Abelson A; Nunez GT; Njindam IM; Kurani S; Baral S
    Trauma Violence Abuse; 2022 Apr; 23(2):676-694. PubMed ID: 35144502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review.
    Bozzani FM; Terris-Prestholt F; Quaife M; Gafos M; Indravudh PP; Giddings R; Medley GF; Malhotra S; Torres-Rueda S
    Pharmacoeconomics; 2023 May; 41(5):467-480. PubMed ID: 36529838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
    Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review on cost effectiveness of HIV prevention interventions in the United States.
    Huang YL; Lasry A; Hutchinson AB; Sansom SL
    Appl Health Econ Health Policy; 2015 Apr; 13(2):149-56. PubMed ID: 25536927
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.